Vineet Laboratories Limited has deferred its board meeting originally scheduled for July 15, 2026, due to unavoidable circumstances. The meeting was intended to consider and approve the audited financial results for the financial year ended March 31, 2026, a critical disclosure for shareholders assessing the company's annual performance.

The deferment impacts the timeline for the release of the FY26 financial results, which were to be approved pursuant to Regulation 29 read with Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. The company stated that a fresh notice specifying the revised date, time, and venue of the board meeting would be intimated to the stock exchanges in due course.

The intimation was addressed to BSE Limited and National Stock Exchange of India Limited, confirming that the regulatory bodies have been notified of the delay. The company’s scrip codes are 543298 on BSE and VINEETLAB on NSE.

Vineet Laboratories Limited has assured that the revised schedule will be communicated in accordance with the requirements of Regulation 29 of the SEBI Listing Regulations. The deferral was signed by Gaddam Venkata Ramana, Managing Director.

Vineet Laboratories confirmed that its promoters have not encumbered any shares during the financial year ended March 31, 2026. The declaration, submitted to the stock exchanges, assures stakeholders that no new charges have been created on the promoter holdings, other than those previously disclosed. This compliance filing is mandatory under the SEBI (Substantial Acquisition of Shares and Takeovers) Regulations, 2011 to maintain transparency regarding shareholding patterns.

The disclosure was made by A Srinivasa Raju, a promoter, on behalf of all promoters and Persons Acting in Concert (PACs). The filing confirms that the group, which holds a total of 11,49,097 equity shares, has not pledged or otherwise encumbered these shares directly or indirectly during FY26. The company’s registered office is located at SY. No. 11/A3, Saheb Nagar, Kurdu Vill, Chintal Kunta, Eshwaramma Nilayam, L B Nagar, Hyderabad.

Regulatory Compliance

The declaration was submitted in accordance with Regulation 31(4) of the SEBI (Substantial Acquisition of Shares and Takeovers) Regulations, 2011. This regulation requires promoters to disclose any encumbrance on their holdings to ensure that the market is aware of any potential risks associated with the pledged shares. The communication was addressed to the General Manager of the Department of Corporate Services at BSE Limited and the Manager of the Listing Department at the National Stock Exchange of India Limited.

Shareholding Details

The following table outlines the key details of the shareholding covered under this declaration:

The document serves as a formal confirmation to the Audit Committee and the stock exchanges regarding the status of the promoter holdings. By confirming the absence of encumbrances, vineet laboratories provides clarity to investors concerning the financial standing of its primary shareholders.